• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Maes, T
    Mascaró, C
    Ortega, A
    Lunardi, S
    Ciceri, F
    Somervaille, Tim C P
    Buesa, C
    Affiliation
    Oryzon Genomics S.A., Carrer Sant Ferran 74, 08940 Cornella de Llobregat, Barcelona,
    Issue Date
    2015-06
    
    Metadata
    Show full item record
    Abstract
    Histone methylation and demethylation are important processes associated with the regulation of gene transcription, and alterations in histone methylation status have been linked to a large number of human diseases. Initially thought to be an irreversible process, histone methylation is now known to be reversed by two families of proteins containing over 30 members that act to remove methyl groups from specific lysine residues present in the tails of histone H3 and histone H4. A rapidly growing number of reports have implicated the FAD-dependent lysine specific demethylase (KDM1) family in cancer, and several small-molecule inhibitors are in development for the treatment of cancer. An additional role has emerged for KDM1 in brain function, offering additional opportunities for the development of novel therapeutic strategies in neurodegenerative disease. A decade after the identification of KDM1A as a histone demethylase, the first selective inhibitors have now reached the clinic.
    Citation
    KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease. 2015, 7 (4):609-26 Epigenomics
    Journal
    Epigenomics
    URI
    http://hdl.handle.net/10541/560945
    DOI
    10.2217/epi.15.9
    PubMed ID
    26111032
    Type
    Article
    Language
    en
    ISSN
    1750-192X
    ae974a485f413a2113503eed53cd6c53
    10.2217/epi.15.9
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
    • Authors: Mao F, Shi YG
    • Issue date: 2023
    • Histone demethylases in neurodevelopment and neurodegenerative diseases.
    • Authors: Wang H, Guo B, Guo X
    • Issue date: 2024 Nov
    • A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    • Authors: Hosseini A, Minucci S
    • Issue date: 2017 Aug
    • Structural insights into histone lysine demethylation.
    • Authors: Hou H, Yu H
    • Issue date: 2010 Dec
    • Targeting histone lysine demethylases - progress, challenges, and the future.
    • Authors: Thinnes CC, England KS, Kawamura A, Chowdhury R, Schofield CJ, Hopkinson RJ
    • Issue date: 2014 Dec
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.